Chief Executive Officer
Charlie joined Kolosis in January of 2023 to build out the company’s sales organization in the Eastern and Southern US states.
Prior to joining Kolosis, Charlie served as General Manager for an exclusive NuVasive distributorship in North Carolina/Virginia and later as Area Sales Manager for a spine and orthobiologics direct sales team. Previously, Charlie held multiple leadership positions within Orthofix’s Biologics and Spine divisions representing MTF bone graft technologies. Three times, Charlie was named Orthofix Biologics Regional Manager of the Year as the top revenue producer.
Charlie graduated from Wake Forest University with a degree in Biology.